Drug Interactions Analgesics—Salicylates

Anon.: Effects of Drugs on the PBI and T₃ Uptake, Med. Letter, 9: 82 (Oct. 20) 1967. (R).

Barrow M. V. : Salicylate Hypoprothombinemia in Rheumatoid Arthritis with Liver Disease, Arch. Internal Med. 120: 620 (Nov.) 1967. (CH).

Bluestone R. : Effect of Drugs on Urate Binding to Plasma Proteins, Brit. Med. J. 4: 590 (Dec. 6) 1969. (OH).

Deykin D. : Current Concepts: Warfarin Therapy, New Engl. J. Med. 283: 801 (Oct. 8) 1970. (R).

Dixon R. L. : Plasma Protein Binding of Methotrexate and Its Displacement by Various Drugs, Fed. Proc. 24: 454, 1965 (Abstract).

Done A. K. : Developmental Pharmacology, Clin. Pharmacol. Therap. 5: 432 (July–Aug.) 1964. (R).

Dry T. J. : Effect of Oral Administration of Para-Aminobenzoic Acid on Concentration of Salicylates in Blood, Preliminary Report, Proc. Mayo Clin. 21: 497 (Dec.) 1946. (OCH).

Elliot H. C. : Reduced Adrenocortocal Steroid Excretion Rates in Man Following Aspirin Administration, Metabolism 11: 1015 (Sept.) 1962. (OH).

Field J. B. : Effect of Salicylate Infusion on Plasma-Insulin and Glucose Tolerance in Healthy Persons and Mild Diabetics, Lancet 1: 1191 (June 3) 1967. (OH).

Glynn K. P. : False Elevation of Serum Glutamic Oxalacetic Transaminase Due to Para-Aminosalicylic Acid, Ann. Internal Med. 72: 525 (Apr.) 1970. (OH).

Goodman L. S. Gilman A. : The Pharmacological Basis of Therapeutics, 4th ed., MacMillan Co., N. Y. 1970-a-316, b-320, c-324, d-326, e-327.

Grotto M. : Additive and Augmentative Synergism Between Analgesic Drugs, Arch. Intern. Pharmacodyn. 155: 365 (June) 1965. (OA).

Hansten P. D. : Drug Interactions, Lea & Febiger, Phila. 1971.

Harker L. A. Slichter S. J. : Studies of Platelet and Fibrinogen Kinetics in Patients with Prosthetic Heart Valves, New Engl. J. Med. 282: 1302 (Dec. 10) 1970. (OH).

Klinenberg J. R. Miller F. : Effect of Corticosteroids on Blood Salicylate Concentration, J. Am. Med. Assoc. 194: 601 (Nov. 8) 1965. (CHO).

Krondl A. : Present Understanding of the Interactions of Drugs and Food During Absorption, Can. Med. Assoc. J. 103: 360 (Aug. 15) 1970. (R).

Kunin C. M. : Enhancement of Antimicrobial Activity of Penicillins and Other Antibiotics in Human Serum by Competitive Serum Binding Inhibitors, Proc. Soc. Exptl. Biol. Med. 117: 69 (Oct.) 1964. (OT).

Kunin C. M. : Clinical Pharmacology of the New Penicillins II. Effect of Drugs Which Interfere with Binding to Serum Proteins, Clin. Pharmacol. Therap. 7: 180 (Mar.-Apr.) 1966. (OHT).

Levy G. Procknol J. A. : Drug Biotransformation Interactions in Man, 1. Mutual Inhibition in Glucuronide Formation of Salicylic Acid and Salicylamide in Man, J. Pharm. Sci. 57: 1330 (Aug.) 1968. (OH).

Liegler D. G. : The Effect of Organic Acids on Renal Clearance of Methotrexate in Man, Clin. Pharmacol. Therap. 10: 849 (Nov.–Dec.) 1969. (OAH).

Lunde P. K. M. : Plasma Protein Binding of Diphenylhydantoin in Man, Clin. Pharmacol. Therap. 11: 846 (Nov.–Dec.) 1970. (OTH).

Mielens Z. E. : Interaction of Aspirin with Nonsteroidal Anti-Inflammatory Drugs in Rats, J. Pharm. Pharmacol. 20: 567 (July) 1968. (OA).

Odell G. B. : The Dissociation of Bilirubin from Albumin and Its Clinical Implication, J. Pediat. 55: 268 (Sept.) 1959. (R).

Oyer J. H. : Suppression of Salicylate-Induced Uricosuria by Phenylbutazone, Am. J. Med. Sci. 251: 1 (Jan.) 1966. (OH).

Parker W. J. : Clinically Significant Alcohol-Drug Interactions, J. Am. Pharm. Assoc. NS10: 664 (Dec.) 1970. (R).

Peaston M. J. T. Finnegan P. : A Case of Combined Poisoning with Chlorpropamide, Acetylsalicylic Acid and Paracetamol. Brit. J. Clin. Pract. 22: 30 (Jan.) 1968. (OH).

Reilly M. J. : Am. Hospital Formulary Service, Am. Soc. Hosp. Pharm., Washington, D.C. — A — Glucose Oxidase Reagent, B — Allopurinol.

Sigell L. T. Flessa H. C. : Drug Interactions with Anticoagulants, J. Am. Med. Assoc. 214: 2035 (Dec. 14) 1970. (R).

Solomon H. M. : Pitfalls of Drug Interference with Coumarin Anticoagulants, Hosp. Practice 3: 51 (July) 1968. (R).

Stowers J. M. : A Clinical and Pharmacological Comparison of Chlorpropamide and Other Sulfonylureas, Ann. N. Y. Acad. Sci. 74: 689 (Mar.) 1959. (ROH).

Sullivan J. M. : Pharmacologic Control of Thromboembolic Complications of Cardiac Valve Replacement, New Engl. J. Med. 279: 576 (Sept. 12) 1968.

Sullivan J. M. : Effect of Dipyridamole on the Incidence of Arterial Emboli After Cardiac Valve Replacement, Circulation (Suppl.) 39: 1, 1969.

Udall J. A. : Drug Interference with Warfarin Therapy, Am. J. Cardiol. 23: 143 (Jan.) 1969. (Abstract) (OH).

Wishinsky H. : Protein Interactions of Sulfonylurea Compounds, Diabetes 11: (Suppl.) 18, 1962. (OT) Additional References Not Available to the Reviewer.

Baker H. : Intermittent High Dose Oral Methotrexate Therapy in Psoriasis, Brit. J. Dermatol. 82: 65 (Jan.) 1970. (CH).

Jeremy R. Towson J. : Med. J. Australia 2: 127 (July 18) 1970.

Reisterer J. Jacques R. : Interference by β-Adrenergic Blocking Agents, with the Anti-Inflammatory Action of Various Drugs, Helv. Physiol. Acta 26: 287, 1968.

Yesais D. W. : Comparative Effects of Salicylic Acid, Phenylbutazone, Probenecid and Other Anions on the Metabolism, Distribution and Excretion of Indomethacin in Rats, Biochem. Pharmacol. 19: 1591 (May) 1970.